# Ginkgo Bioworks Holdings, Inc.: Form 8-K, filed Feb 27, 2026

- Company: [Ginkgo Bioworks Holdings, Inc.](/companies/dna.md) (CIK 1830214)
- Form: 8-K
- Filed: 2026-02-27
- Accepted by EDGAR: Feb 26, 2026, 21:56 ET
- Period: 2026-02-26
- Accession: 0001628280-26-012552
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1830214/000162828026012552/dna-20260226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1830214/000162828026012552/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1830214/000162828026012552/dna-20260226.htm

Filed Feb 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-012552. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.